Voriconazole: Difference between revisions

From IDWiki
No edit summary
No edit summary
Line 1: Line 1:
== Therapeutic Drug Monitoring ==
== Dosing ==
* Measure trough within 7 days of starting, and at regular intervals or following dose adjustment
* Target trough > 1 mg/L for prophylaxis and treatment


{| class="wikitable"
{| class="wikitable"
! Trough (mcg/mL)
! Trough (mcg/mL) !! Recommendation
! Recommendation
|-
|-
| 0.0 to 0.6 || Increase dose by 100 mg and recheck trough on day 5 of new regimen
| 0.0 to 0.6
| Increase dose by 100 mg and recheck trough on day 5 of new regimen
|-
|-
| 0.7 to 0.9 || Increase dose by 50 mg and recheck trough on day 5 of new regimen
| 0.7 to 0.9
| Increase dose by 50 mg and recheck trough on day 5 of new regimen
|-
|-
| 1.0 to 4.0
| 1.0 to 4.0 || At target, no dose adjustment needed
| At target, no dose adjustment needed
|-
|-
| 4.1 to 5.5 || Decrease dose by 50 mg and recheck trough on day 5 of new regimen
| 4.1 to 5.5
| Decrease dose by 50 mg and recheck trough on day 5 of new regimen
|-
|-
| 5.6 to 7.9 || Hold dose. Follow daily trough levels, then restart when trough is ≤2.5 at a dose decreased by 100 mg. Recheck trough on day 5 of new regimen.
| 5.6 to 7.9
| Hold dose. Follow daily trough levels, then restart when trough is ≤2.5 at a dose decreased by 100 mg. Recheck trough on day 5 of new regimen.
|-
|-
| ≥8.0 || Hold dose. Follow daily trough levels, then restart when trough is ≤2.5 at a dose decreased by 50%. Recheck trough level on day 5 of new regimen.
| ≥8.0
| Hold dose. Follow daily trough levels, then restart when trough is ≤2.5 at a dose decreased by 50%. Recheck trough level on day 5 of new regimen.
|}
|}


== Adverse Effects ==
== Adverse Effects ==

* Visual
* Visual
** Floaters etc that may improve with time
** Floaters etc that may improve with time
Line 33: Line 27:


== Further Reading ==
== Further Reading ==

* [https://doi.org/10.1093/ofid/ofv133.527 Voriconazole Dose Modification Guideline to Optimize Therapeutic Levels in Patients With Hematologic Malignancies]. ''Open Forum Infect Dis''. 2015(2)S1:810.
* [https://doi.org/10.1093/ofid/ofv133.527 Voriconazole Dose Modification Guideline to Optimize Therapeutic Levels in Patients With Hematologic Malignancies]. ''Open Forum Infect Dis''. 2015(2)S1:810.



Revision as of 01:41, 21 November 2019

Therapeutic Drug Monitoring

  • Measure trough within 7 days of starting, and at regular intervals or following dose adjustment
  • Target trough > 1 mg/L for prophylaxis and treatment
Trough (mcg/mL) Recommendation
0.0 to 0.6 Increase dose by 100 mg and recheck trough on day 5 of new regimen
0.7 to 0.9 Increase dose by 50 mg and recheck trough on day 5 of new regimen
1.0 to 4.0 At target, no dose adjustment needed
4.1 to 5.5 Decrease dose by 50 mg and recheck trough on day 5 of new regimen
5.6 to 7.9 Hold dose. Follow daily trough levels, then restart when trough is ≤2.5 at a dose decreased by 100 mg. Recheck trough on day 5 of new regimen.
≥8.0 Hold dose. Follow daily trough levels, then restart when trough is ≤2.5 at a dose decreased by 50%. Recheck trough level on day 5 of new regimen.

Adverse Effects

  • Visual
    • Floaters etc that may improve with time
    • Visual hallucinations
  • Hepatotoxicity
  • QTc prolongation

Further Reading